Redox nanomedicine ameliorates chronic kidney disease (CKD) by mitochondrial reconditioning in mice
Open Access
- 26 August 2021
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 4 (1) , 1-15
Abstract
Targeting reactive oxygen species (ROS) while maintaining cellular redox signaling is crucial in the development of redox medicine as the origin of several prevailing diseases including chronic kidney disease (CKD) is linked to ROS imbalance and associated mitochondrial dysfunction. Here, we have shown that a potential nanomedicine comprising of Mn3O4 nanoparticles duly functionalized with biocompatible ligand citrate (C-Mn3O4 NPs) can maintain cellular redox balance in an animal model of oxidative injury. We developed a cisplatin-induced CKD model in C57BL/6j mice with severe mitochondrial dysfunction and oxidative distress leading to the pathogenesis. Four weeks of treatment with C-Mn3O4 NPs restored renal function, preserved normal kidney architecture, ameliorated overexpression of pro-inflammatory cytokines, and arrested glomerulosclerosis and interstitial fibrosis. A detailed study involving human embryonic kidney (HEK 293) cells and isolated mitochondria from experimental animals revealed that the molecular mechanism behind the pharmacological action of the nanomedicine involves protection of structural and functional integrity of mitochondria from oxidative damage, subsequent reduction in intracellular ROS, and maintenance of cellular redox homeostasis. To the best of our knowledge, such studies that efficiently treated a multifaceted disease like CKD using a biocompatible redox nanomedicine are sparse in the literature. Successful clinical translation of this nanomedicine may open a new avenue in redox-mediated therapeutics of several other diseases (e.g., diabetic nephropathy, neurodegeneration, and cardiovascular disease) where oxidative distress plays a central role in pathogenesis.Keywords
All Related Versions
Funding Information
- Indian National Academy of Engineering (INAE), SERB, DST, Govt. of India
This publication has 95 references indexed in Scilit:
- Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic FunctionsPLOS ONE, 2013
- Chronic kidney disease: global dimension and perspectivesThe Lancet, 2013
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signalingCellular Signalling, 2012
- Mitochondria and cell signallingJournal of Cell Science, 2012
- Elevated CO2 Levels Cause Mitochondrial Dysfunction and Impair Cell ProliferationJournal of Biological Chemistry, 2011
- Suramin Inhibits Renal Fibrosis in Chronic Kidney DiseaseJournal of the American Society of Nephrology, 2011
- Mitochondria-Targeted Peptide Accelerates ATP Recovery and Reduces Ischemic Kidney InjuryJournal of the American Society of Nephrology, 2011
- Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysisThe Lancet, 2010
- Prohibitins control cell proliferation and apoptosis by regulating OPA1-dependent cristae morphogenesis in mitochondriaGenes & Development, 2008
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006